Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: Cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-lnduced mouse model

Investigative Radiology

Volumn 49, Issue 11, 2014, Pages 691-698

  Velde, Greetje Vande ^a   De Langhe, Ellen ^b,c   Poelmans, Jennifer ^a   Dresselaers, Tom ^a   Lories, Rik J ^b,c   Himmelreich, Uwe ^a  

^a DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^b SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bleomycin; In vivo; Lung; Micro CT; Mouse; MRI; Pulmonary fibrosis; Self gated MRI; Ute

Indexed keywords

BLEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BREATHING; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; IN VIVO STUDY; INTERMETHOD COMPARISON; ISOLATED LUNG; MALE; MICRO COMPUTED TOMOGRAPHY SCANNER; MICRO-COMPUTED TOMOGRAPHY; MOTION; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION STUDY; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; IMAGE PROCESSING; LUNG; PATHOLOGY; PROCEDURES; PULMONARY FIBROSIS; RADIOGRAPHY; REPRODUCIBILITY; ULTRASTRUCTURE;

ANIMALS; BLEOMYCIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; REPRODUCIBILITY OF RESULTS; X-RAY MICROTOMOGRAPHY;

EID: 84925942718     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000071     Document Type: Article

References (32)

1. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431-440.
2. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L152-L160.
3. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40:362-382.
4. De Langhe E, Vande Velde G, Hostens J, et al. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One. 2012;7:e43123.
5. Vande Velde G, Poelmans J, De Langhe E, et al. To beam or not to beam: answers to potential radiotoxicity concerns in longitudinal mouse lung μCT studies. World Molecular Imaging Congress. Savannah, Georgia; 2013. Available at: www.wmis.org/abstracts/2013/data/papers/P200.htm.
6. Plathow C, Li M, Gong P, et al. Computed tomography monitoring of radiationinduced lung fibrosis in mice. Invest Radiol. 2004;39:600-609.
7. Graves PR, Siddiqui F, Anscher MS, et al. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol. 2010;20:201-207.
8. Robson MD, Gatehouse PD, Bydder M, et al. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J Comput Assist Tomogr. 2003;27:825-846.
9. Karmouty-Quintana H, Cannet C, Zurbruegg S, et al. Bleomycin-induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI. J Magn Reson Imaging. 2007;26:941-949.
10. Babin AL, Cannet C, Gerard C, et al. Noninvasive assessment of bleomycininduced lung injury and the effects of short-term glucocorticosteroid treatment in rats using MRI. J Magn Reson Imaging. 2011;33:603-614.
11. Jacob RE, Amidan BG, Soelberg J, et al. In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis. J Magn Reson Imaging. 2010;31:1091-1099.
12. Babin AL, Cannet C, Gerard C, et al. Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis. Magn Reson Med. 2012;67:499-509.
13. Bergin CJ, Pauly JM, Macovski A. Lung parenchyma: projection reconstruction MR imaging. Radiology. 1991;179:777-781.
14. Ohno Y, Nishio M, Koyama H, et al. Pulmonary 3 T MRI with ultrashort TEs: influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers. J Magn Reson Imaging. 2014;39:988-997.
15. Lederlin M, Cremillieux Y. Three-dimensional assessment of lung tissue density using a clinical ultrashort echo time at 3 tesla: a feasibility study in healthy subjects. J Magn Reson Imaging. 2013. doi: 10.1002/jmri.24429.
16. Zurek M, Bessaad A, Cieslar K, et al. Validation of simple and robust protocols for high-resolution lung proton MRI in mice. Magn Reson Med. 2010;64:401-407.
17. Takahashi M, Togao O, Obara M, et al. Ultra-short echo time (UTE) MR imaging of the lung: comparison between normal and emphysematous lungs in mutant mice. J Magn Reson Imaging. 2010;32:326-333.
18. Wurnig MC, Tsushima Y, Weiger M, et al. Assessing lung transplantation ischemia-reperfusion injury by microcomputed tomography and ultrashort echo-time magnetic resonance imaging in a mouse model. Invest Radiol. 2014;49:23-28.
19. van Heeswijk RB, Bonanno G, Coppo S, et al. Motion compensation strategies in magnetic resonance imaging. Crit Rev Biomed Eng. 2012;40:99-119.
20. Heijman E, de Graaf W, Niessen P, et al. Comparison between prospective and retrospective triggering for mouse cardiac MRI. NMR Biomed. 2007;20:439-447.
21. Hiba B, Richard N, Janier M, et al. Cardiac and respiratory double self-gated cine MRI in the mouse at 7 T. Magn Reson Med. 2006;55:506-513.
22. Fries P, Seidel R, Muller A, et al. Comparison of self-gated and prospectively triggered fast low angle shot (FLASH) sequences for contrast-enhanced magnetic resonance imaging of the liver at 9.4 T in a rat model of colorectal cancer metastases. Invest Radiol. 2013;48:738-744.
23. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467-470.
24. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961;93:440-447.
25. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135-160.
26. Egger C, Cannet C, Gerard C, et al. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One. 2013;8:e63432.
27. Zurek M, Boyer L, Caramelle P, et al. Longitudinal and noninvasive assessment of emphysema evolution in a murine model using proton MRI. Magn Reson Med. 2012;68:898-904.
28. Wielputz M, Kauczor HU. MRI of the lung: state of the art. Diagn Interv Radiol. 2012;18:344-353.
29. Scotton CJ, Chambers RC. Bleomycin revisited: towards a more representative model of IPF? Am J Physiol Lung Cell Mol Physiol. 2010;299:L439-441.
30. Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83:111-119.
31. Jin GY, Bok SM, Han YM, et al. Effectiveness of rosiglitazone on bleomycininduced lung fibrosis: assessed by micro-computed tomography and pathologic scores. Eur J Radiol. 2012;81:1901-1906.
32. Scotton CJ, Hayes B, Alexander R, et al. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation. Eur Respir J. 2013;42:1633-1645.